PDB39 Dosing Patterns Among Patients with Type 2 Diabetes (T2D) Initiating Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) in France and the Netherlands
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.436
https://www.valueinhealthjournal.com/article/S1098-3015(21)00653-7/fulltext
Title :
PDB39 Dosing Patterns Among Patients with Type 2 Diabetes (T2D) Initiating Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) in France and the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00653-7&doi=10.1016/j.jval.2021.04.436
First page :
Section Title :
Open access? :
No
Section Order :
10996